We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
+2.26%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$3.42B
AUM Growth
-$3.55B
(-51%)
Cap. Flow
-$6.15B
Cap. Flow
% of AUM
-179.9%
Top 10 Holdings %
Top 10 Hldgs %
20.13%
Holding
4,628
New
1,022
Increased
432
Reduced
2,408
Closed
560
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
+$122M |
| 2 |
Vanguard Value ETF
VTV
|
+$91.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$58.4M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$56.3M |
| 5 |
Vanguard Mid-Cap ETF
VO
|
+$52.1M |
Top Sells
Sector Composition
| 1 | Technology | 9.32% |
| 2 | Financials | 5.1% |
| 3 | Healthcare | 4.19% |
| 4 | Consumer Discretionary | 3.06% |
| 5 | Industrials | 2.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
Talkspace
TALK
$876M
| $51 | ﹤0.01% |
14
-14
| -50% | -$44 |
|
3902
Achieve Life Sciences
ACHV
$627M
| $50 | ﹤0.01% |
10
| – | – |
|
3903
Orion Group Holdings
ORN
$556M
| $50 | ﹤0.01% |
5
-3,339
| -100% | -$32.4K |
|
|
PINE
3904
Alpine Income Property Trust
PINE
$340M
| $50 | ﹤0.01% |
3
-798
| -100% | -$12.5K |
|
3905
Direxion Daily Utilities Bull 3X ETF
UTSL
$45.6M
| $50 | ﹤0.01% |
+1
| New | +$45 |
|
|
BCAX
3906
Bicara Therapeutics
BCAX
$1.9B
| $50 | ﹤0.01% |
3
-67
| -96% | -$1.14K |
|
3907
Aveanna Healthcare
AVAH
$2.11B
| $49 | ﹤0.01% |
6
-3,694
| -100% | -$33.4K |
|
3908
Black Diamond Therapeutics
BDTX
$109M
| $49 | ﹤0.01% |
20
-46
| -70% | -$163 |
|
3909
Maravai LifeSciences
MRVI
$898M
| $49 | ﹤0.01% |
15
-824
| -98% | -$2.77K |
|
3910
Smith & Wesson
SWBI
$698M
| $49 | ﹤0.01% |
5
-952
| -99% | -$9.19K |
|
3911
SmartRent
SMRT
$199M
| $48 | ﹤0.01% |
24
-4,418
| -99% | -$7.24K |
|
3912
Amprius Technologies
AMPX
$1.63B
| $47 | ﹤0.01% |
6
-394
| -99% | -$4.5K |
|
|
JBIO
3913
Jade Biosciences
JBIO
$1.28B
| $47 | ﹤0.01% |
3
-152
| -98% | -$1.78K |
|
3914
GrafTech
EAF
$153M
| $47 | ﹤0.01% |
3
| – | – |
|
3915
Lineage Cell Therapeutics
LCTX
$319M
| $47 | ﹤0.01% |
28
-90
| -76% | -$156 |
|
3916
Lexicon Pharmaceuticals
LXRX
$986M
| $47 | ﹤0.01% |
41
-5,056
| -99% | -$6.95K |
|
|
URG
3917
Ur-Energy
URG
$524M
| $47 | ﹤0.01% |
34
-127
| -79% | -$188 |
|
3918
AlTi Global
ALTI
$396M
| $46 | ﹤0.01% |
10
-797
| -99% | -$3.29K |
|
3919
loanDepot
LDI
$607M
| $46 | ﹤0.01% |
22
-1,031
| -98% | -$2.86K |
|
|
ONIT
3920
Onity Group
ONIT
$327M
| $46 | ﹤0.01% |
1
-469
| -100% | -$19.3K |
|
3921
Aquestive Therapeutics
AQST
$517M
| $45 | ﹤0.01% |
7
-161
| -96% | -$1K |
|
3922
Cadiz
CDZI
$370M
| $45 | ﹤0.01% |
8
-2,816
| -100% | -$15.1K |
|
3923
Designer Brands
DBI
$280M
| $45 | ﹤0.01% |
6
-8,004
| -100% | -$38.5K |
|
3924
Nano X Imaging
NNOX
$73.1M
| $45 | ﹤0.01% |
16
+15
| +1,500% | +$54 |
|
3925
Forafric Global
AFRI
$286M
| $44 | ﹤0.01% |
4
-68
| -94% | -$659 |
|
Similar funds
AC
TYCC
PL
VA
TH
RSWM
ACA
AL